Page last updated: 2024-11-03

propranolol and Tachycardia, Ventricular

propranolol has been researched along with Tachycardia, Ventricular in 50 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0."5.30Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997)
"The effects of pretreatment with cariporide on myocardial infarction and ventricular arrhythmias in a rat model of ischemia/reperfusion were compared with those of nicorandil, propranolol, and nifedipine."3.72Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs. ( Beguier, B; Wajima, T; Yaguchi, M, 2004)
" Prenatal treatment with beta-adrenergic blocker (propranolol) and digitalis glycosides was prescribed because of suspicion of long QT syndrome occurring with fetal congestive heart failure."3.71Prenatal diagnosis and treatment of fetal long QT syndrome: a case report. ( Chang, IK; Chow, SN; Hsieh, FJ; Kau, ML; Ko, YH; Lee, CN; Shyu, MK, 2002)
"The proarrhythmic effects of 3-hydroxy-hydroquinidine (3-OH-HQ) and quinidine were compared in a canine model of QT-dependent ventricular arrhythmias."3.69Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block. ( Cheymol, G; Chézalviel-Guilbert, F; Davy, JM; Guhennec, C; Poirier, JM; Weissenburger, J, 1995)
" In hyperthyroidism late potentials may be eliminated rapidly by propranolol even in low dosages."3.69[Late potentials in high resolution ECG in thyroid gland dysfunction]. ( Buchinger, W; Eber, O; Költringer, P; Schippinger, W; Schubert, B, 1995)
"The use of propranolol is generally contraindicated in patients with congestive heart failure."3.68Successful treatment of life-threatening ventricular tachycardia with high-dose propranolol under extracorporeal life support and intraaortic balloon pumping. ( Goto, H; Kurose, M; Ogata, K; Okamoto, K; Okumura, K; Sato, T; Terasaki, H; Yasumoto, M; Yatsuda, R, 1993)
"Verapamil was more effective than the dihydropyridine L-type Ca(2+) channel blocker nifedipine, and its activity was markedly enhanced when combined with propranolol."2.75Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice. ( Arad, M; Eldar, M; Hochhauser, E; Katz, G; Khoury, A; Kurtzwald, E; Lorber, A; Porat, E; Seidman, CE; Seidman, JG; Shainberg, A, 2010)
"Idiopathic left ventricular tachycardia (VT) has been classified into three subgroups according to mechanism: verapamil-sensitive, adenosine-sensitive, and propranolol-sensitive types."2.41Idiopathic left ventricular tachycardia: assessment and treatment. ( Nogami, A, 2002)
"The most common form of idiopathic ventricular tachycardia originates from the right ventricular outflow tract, is characterized by sensitivity to adenosine, and appears to be due to cyclic AMP-mediated triggered activity."2.41Management of ventricular tachycardia in patients with clinically normal hearts. ( Iwai, S; Lerman, BB, 2000)
"Polymorphic ventricular tachycardia (PMVT) is a rare genetic disease associated with structurally normal hearts which in 8% of cases can lead to sudden cardiac death, typically exercise-induced."1.91Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes. ( Charrabi, A; Chen, S; Cheung, JW; Colombani, S; Evans, T; Jaffré, F; Lacampagne, A; Lerman, BB; Marks, AR; Meli, AC; Pasquié, JL; Reiken, S; Sittenfeld, LR; Sleiman, Y, 2023)
"Leptin has been proposed to modulate cardiac electrical properties via β-adrenergic receptor activation."1.42Leptin decreases heart rate associated with increased ventricular repolarization via its receptor. ( Davis, M; Hileman, S; Huang, J; Hull, R; Lin, YC; Martin, KH; Yu, HG, 2015)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial arrhythmic syndrome caused by mutations in genes encoding the calcium-regulation proteins cardiac ryanodine receptor (RyR2) or calsequestrin-2 (CASQ2)."1.37Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. ( Alcalai, R; Arad, M; Berul, CI; Konno, T; Planer, D; Seidman, CE; Seidman, JG; Wakimoto, H; Wang, L, 2011)
"Monomorphic ventricular tachycardia (VT) is a unique manifestation of hyperthyroidism."1.36Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis. ( Chandra, AB; Chandra, PA; Ghosh, J; Pednekar, M; Vallakati, A, 2010)
"Catecholaminergic polymorphic ventricular tachycardia occurs in healthy children and young adults causing syncope and sudden cardiac death."1.35Catecholaminergic polymorphic ventricular tachycardia: a current overview. ( Barreto, JR; Cruz Filho, FE; Fenelon, G; Henz, BD; Leite, LR; Macedo, PG; Santos, SN; Zanatta, A, 2009)
"Ventricular premature beats frequently originated from the peri-infarct zone, and 37% showed elevation of Ca(i) prior to V(m) depolarization, suggesting reverse excitation-contraction coupling as their aetiology."1.34Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts. ( Chen, PS; Chou, CC; Fishbein, MC; Hayashi, H; Lin, SF; Liu, YB; Nihei, M; Weiss, JN; Wen, MS; Wu, D; Yeh, SJ; Zhou, S, 2007)
"Recurrent life-threatening episodes of ventricular tachycardia persisted despite maximal antiarrhythmic theraphy with amiodarone, metoprolol and mexiletine."1.33Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. ( Anastasiou-Nana, MI; Kanakakis, J; Rokas, S; Tsagalou, EP, 2005)
"Idiopathic ventricular tachycardia is rare, especially in infants."1.32Verapamil sensitive idiopathic ventricular tachycardia in an infant. ( Chi, CS; Fu, YC; Jan, SL; Wang, JD, 2003)
"Catecholaminergic polymorphic ventricular tachycardia (VT) is a rare arrhythmogenic disorder, which may cause sudden death and whose relationships with mutations in cardiac ryanodine receptor gene have been recently established."1.32Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. ( Bloise, R; Chiaretti, A; De Rosa, G; Delogu, AB; Piastra, M; Priori, SG, 2004)
"Propranolol or flecainide was added to the treatment protocol for two patients who did not respond to verapamil alone."1.31Idiopathic sustained left ventricular tachycardia in pediatric patients. ( Iwamoto, M; Kobayashi, H; Niimura, I; Nishizawa, T; Sakon, T; Shibata, T; Takigiku, K; Yasui, K; Yokoyama, U, 2001)
"Treatment with bunazosin ameliorated this ischemia-related shortening of refractory periods at both the endo- and epicardial sites, with a greater effect seen epicardially (p < 0."1.30Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia. ( Handa, S; Iwamoto, T; Kusuzaki, S; Takigawa, O; Tanabe, T; Usui, K; Yoshitake, M, 1997)
"Propranolol hydrochloride was administered to 30 patients with stable angina pectoris suffering from coronary heart disease (CHD)."1.29[The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy]. ( Afonskaia, NI; Belogubets, VI; Polevaia, TIu; Smetnev, AS, 1994)
"Dogs with an inherited predisposition to sudden death display ventricular arrhythmias having certain characteristics, such as pause dependence, that are suggestive of early afterdepolarization-induced triggered activity."1.29Phenylephrine-induced ventricular arrhythmias in dogs with inherited sudden death. ( Brittain, D; Flahive, WJ; Gilmour, RF; Lee, RJ; Lewis, BA; Moïse, NS; Moon, PF; Pride, HP; Zipes, DP, 1996)
"Exercise-induced ventricular tachycardia (VT) without demonstrable heart disease was studied in pediatric patients."1.29Exercise-induced ventricular tachycardia without demonstrable heart disease in childhood. ( Baba, R; Goto, M; Nagano, Y; Nagashima, M; Nishabata, K, 1996)

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's22 (44.00)18.2507
2000's16 (32.00)29.6817
2010's8 (16.00)24.3611
2020's4 (8.00)2.80

Authors

AuthorsStudies
Sun, Q1
Wang, F1
Zheng, R1
Xie, Z1
Jia, L1
Li, D1
Sleiman, Y1
Reiken, S1
Charrabi, A1
Jaffré, F1
Sittenfeld, LR1
Pasquié, JL1
Colombani, S1
Lerman, BB2
Chen, S1
Marks, AR1
Cheung, JW1
Evans, T1
Lacampagne, A1
Meli, AC1
Kusayama, T1
Chen, PS2
Vaksmann, G1
Lucidarme, S1
Henriet, E1
Cafferkey, A1
McMahon, C1
Nagatome, Y1
Ueno, K1
Takahashi, Y1
Hazeki, D1
Kawano, Y1
Puljević, M1
Velagić, V1
Puljević, D1
Miličić, D1
Lin, YC1
Huang, J1
Hileman, S1
Martin, KH1
Hull, R1
Davis, M1
Yu, HG1
Leite, LR1
Henz, BD1
Macedo, PG1
Santos, SN1
Barreto, JR1
Zanatta, A1
Fenelon, G1
Cruz Filho, FE1
Katz, G1
Khoury, A1
Kurtzwald, E1
Hochhauser, E1
Porat, E1
Shainberg, A1
Seidman, JG2
Seidman, CE2
Lorber, A1
Eldar, M2
Arad, M2
Alcalai, R1
Wakimoto, H1
Planer, D1
Konno, T1
Wang, L1
Berul, CI1
Chandra, PA1
Vallakati, A1
Chandra, AB1
Pednekar, M1
Ghosh, J1
de Oliveira, FC1
Feitosa-Filho, GS1
Ritt, LE1
Nogami, A1
Chang, IK1
Shyu, MK1
Lee, CN1
Kau, ML1
Ko, YH1
Chow, SN1
Hsieh, FJ1
Pras, E1
Lahat, H1
Wang, JD1
Fu, YC1
Jan, SL1
Chi, CS1
Wajima, T1
Beguier, B1
Yaguchi, M1
Tassone, H1
Moulin, A1
Henderson, SO1
De Rosa, G1
Delogu, AB1
Piastra, M1
Chiaretti, A1
Bloise, R1
Priori, SG1
Tsagalou, EP1
Kanakakis, J1
Rokas, S1
Anastasiou-Nana, MI1
Komiya, N1
Seto, S1
Nakao, K1
Yano, K1
Hayashi, M1
Okazaki, H1
Igei, S1
Inada, K1
Matuo, S1
Date, T1
Yagi, H1
Yamane, T1
Sugimoto, K1
Mochizuki, S1
Chou, CC1
Zhou, S1
Hayashi, H3
Nihei, M1
Liu, YB1
Wen, MS1
Yeh, SJ1
Fishbein, MC1
Weiss, JN1
Lin, SF1
Wu, D1
Yamawake, N1
Nishizaki, M1
Hayashi, T1
Niki, S1
Maeda, S1
Tanaka, Y1
Fujii, H1
Ashikaga, T1
Sakurada, H1
Hiraoka, M1
Stengl, M1
Aronow, WS2
Ahn, C2
Mercando, AD2
Epstein, S2
Kronzon, I2
Stramba-Badiale, M1
Lazzarotti, M1
Facchini, M1
Schwartz, PJ1
Belogubets, VI1
Polevaia, TIu1
Afonskaia, NI1
Smetnev, AS1
Chézalviel-Guilbert, F1
Weissenburger, J1
Davy, JM1
Guhennec, C1
Poirier, JM1
Cheymol, G1
Peuhkurinen, KJ1
Huikuri, HV1
Linnaluoto, M1
Takkunen, JT1
McCurdy, CM1
Rutherford, SE1
Coddington, CC1
Kurose, M1
Okamoto, K1
Sato, T1
Yatsuda, R1
Ogata, K1
Yasumoto, M1
Terasaki, H1
Goto, H1
Okumura, K1
Bélichard, P1
Savard, P1
Cardinal, R1
Nadeau, R1
Gosselin, H1
Paradis, P1
Rouleau, JL1
Ishibashi, H1
Fu, L1
Namiki, T1
Sekiguchi, A1
Sagara, K1
Kato, K1
Twidale, N1
Rayner, TE1
Menadue, MF1
Cain, MD1
Tonkin, AM1
Oliver, JR1
Gautam, CS1
Sharma, PL1
Pandhi, P1
Schippinger, W1
Buchinger, W1
Schubert, B1
Költringer, P1
Eber, O1
Moïse, NS1
Moon, PF1
Flahive, WJ1
Brittain, D1
Pride, HP1
Lewis, BA1
Zipes, DP1
Lee, RJ1
Gilmour, RF1
Nagashima, M1
Baba, R1
Goto, M1
Nishabata, K1
Nagano, Y1
Fujiki, A2
Tani, M2
Mizumaki, K2
Shimono, M2
Inoue, H2
Tanabe, T2
Usui, K2
Kusuzaki, S1
Yoshitake, M1
Takigawa, O1
Iwamoto, T1
Handa, S2
Usui, M1
Nagasawa, H1
Shinozaki, Y1
Mori, H1
Zahedi, A1
Grant, MH1
Wong, DT1
Fisher, JD1
Krikler, D1
Hallidie-Smith, KA1
Kou, WH1
Man, KC1
Goyal, R1
Strickberger, SA1
Morady, F1
Iwai, S1
Yasui, K1
Shibata, T1
Yokoyama, U1
Nishizawa, T1
Takigiku, K1
Sakon, T1
Kobayashi, H1
Iwamoto, M1
Niimura, I1

Reviews

4 reviews available for propranolol and Tachycardia, Ventricular

ArticleYear
Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review.
    Resuscitation, 2012, Volume: 83, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Coronary Circulation; Epinephri

2012
Idiopathic left ventricular tachycardia: assessment and treatment.
    Cardiac electrophysiology review, 2002, Volume: 6, Issue:4

    Topics: Adenosine; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Catheter Ablation; Electrocardiog

2002
The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature.
    The Journal of emergency medicine, 2004, Volume: 26, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Emergency Medical Services; Humans; Hyperkalemia; Hyperthyroidism; Hy

2004
Management of ventricular tachycardia in patients with clinically normal hearts.
    Current cardiology reports, 2000, Volume: 2, Issue:6

    Topics: Adenosine; Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Female; Heart Function Te

2000

Trials

3 trials available for propranolol and Tachycardia, Ventricular

ArticleYear
Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.
    Heart rhythm, 2010, Volume: 7, Issue:11

    Topics: Adolescent; Adult; Animals; Anti-Arrhythmia Agents; Child; Female; Humans; Male; Mice; Mice, Transge

2010
Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 40%.
    The American journal of cardiology, 1994, Aug-01, Volume: 74, Issue:3

    Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Echocardiography; Ele

1994
Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect.
    The American journal of cardiology, 1994, Sep-15, Volume: 74, Issue:6

    Topics: Aged; Aged, 80 and over; Coronary Disease; Humans; Middle Aged; Propranolol; Prospective Studies; Si

1994

Other Studies

43 other studies available for propranolol and Tachycardia, Ventricular

ArticleYear
[Clinical and genetic analysis of five children with Catecholaminergic polymorphic ventricular tachycardia due to variants of RYR2 gene].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2023, Aug-10, Volume: 40, Issue:8

    Topics: Child; Humans; Mutation; Propranolol; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycard

2023
Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes.
    Stem cell research & therapy, 2023, 09-23, Volume: 14, Issue:1

    Topics: Anti-Arrhythmia Agents; Calcium; Flecainide; Humans; Myocytes, Cardiac; Precision Medicine; Proprano

2023
Propranolol or SGB, That Is the Question.
    JACC. Clinical electrophysiology, 2020, Volume: 6, Issue:5

    Topics: Arrhythmias, Cardiac; Autonomic Nerve Block; Humans; Propranolol; Stellate Ganglion; Tachycardia, Ve

2020
Fetal ventricular tachycardia: betablockers should be the first line treatment.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Diuretics; Female; Fetal Diseases; Fetal Monitoring; Humans; Inf

2021
Successful Treatment of Refractory Cardiac Arrest With β-Blockade and Extracorporeal Life Support in a Pediatric Patient With Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report.
    A&A practice, 2018, Aug-01, Volume: 11, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atenolo

2018
Neonatal ventricular tachycardia: Adverse event possibly due to maternal ritodrine.
    Pediatrics international : official journal of the Japan Pediatric Society, 2019, Volume: 61, Issue:3

    Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Infant, Newborn; Male; Pregnancy

2019
Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series.
    Croatian medical journal, 2014, Volume: 55, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Defibrillators, Implantable; Female; Humans; M

2014
Leptin decreases heart rate associated with increased ventricular repolarization via its receptor.
    American journal of physiology. Heart and circulatory physiology, 2015, Nov-15, Volume: 309, Issue:10

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Electrophysiological Phenomena; Heart; Hear

2015
Catecholaminergic polymorphic ventricular tachycardia: a current overview.
    Future cardiology, 2009, Volume: 5, Issue:2

    Topics: Adrenergic beta-Antagonists; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Elect

2009
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
    Journal of cardiovascular electrophysiology, 2011, Volume: 22, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium Sign

2011
Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis.
    The American heart hospital journal, 2010,Winter, Volume: 8, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Humans; Male; Methimazole; Propranolol; Tach

2010
Prenatal diagnosis and treatment of fetal long QT syndrome: a case report.
    Prenatal diagnosis, 2002, Volume: 22, Issue:13

    Topics: Adult; Bradycardia; Bundle-Branch Block; Electrocardiography; Female; Fetal Diseases; Heart Block; H

2002
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.
    Cold Spring Harbor symposia on quantitative biology, 2002, Volume: 67

    Topics: Adrenergic beta-Antagonists; Base Sequence; Calsequestrin; Catecholamines; Child; Child, Preschool;

2002
Verapamil sensitive idiopathic ventricular tachycardia in an infant.
    Japanese heart journal, 2003, Volume: 44, Issue:5

    Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Resistance; Drug Therapy, Combination; Electrocardiography;

2003
Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs.
    Pharmacology, 2004, Volume: 70, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiograp

2004
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
    Pediatric emergency care, 2004, Volume: 20, Issue:3

    Topics: Adrenergic beta-Antagonists; Brain Edema; Catecholamines; Child; Decerebrate State; Electrocardiogra

2004
Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
    International journal of cardiology, 2005, Mar-18, Volume: 99, Issue:2

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Defibrillator

2005
The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia.
    Pacing and clinical electrophysiology : PACE, 2005, Volume: 28, Issue:7

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Electrocardiography; Female; Humans; Isoprote

2005
[Catecholaminergic polymorphic ventricular tachycardia successfully treated by beta blocker].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jan-10, Volume: 95, Issue:1

    Topics: Adolescent; Adrenergic beta-Antagonists; Catecholamines; Female; Humans; Isoproterenol; Propranolol;

2006
Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts.
    The Journal of physiology, 2007, May-01, Volume: 580, Issue:Pt.3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiac Complexes

2007
Autonomic and pharmacological responses of idiopathic ventricular tachycardia arising from the left ventricular outflow tract.
    Journal of cardiovascular electrophysiology, 2007, Volume: 18, Issue:11

    Topics: Adenosine Triphosphate; Anti-Arrhythmia Agents; Cardiotonic Agents; Catheter Ablation; Electrophysio

2007
What is more dangerous in long QT 3 syndrome? Arrhythmogenic trigger or substrate?
    Acta physiologica (Oxford, England), 2008, Volume: 192, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Cardiac Electrophysiology; Electric Stimulation; Long QT Syndrome;

2008
Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
    American heart journal, 1994, Volume: 128, Issue:5

    Topics: Animals; Autonomic Nervous System; Cardiac Complexes, Premature; Cats; Electrocardiography; Flecaini

1994
[The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy].
    Terapevticheskii arkhiv, 1994, Volume: 66, Issue:8

    Topics: Adult; Aged; Analysis of Variance; Autonomic Nervous System; Cardiac Complexes, Premature; Drug Eval

1994
Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block.
    Fundamental & clinical pharmacology, 1995, Volume: 9, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dogs; Elec

1995
Changes in myocardial metabolism and transcardiac electrolytes during simulated ventricular tachycardia: effects of beta-adrenergic blockade.
    American heart journal, 1994, Volume: 128, Issue:1

    Topics: Adenine Nucleotides; Blood Pressure; Carbon Dioxide; Cardiac Pacing, Artificial; Coronary Disease; C

1994
Syncope and sudden arrhythmic death complicating pregnancy. A case report of Romano-Ward syndrome.
    The Journal of reproductive medicine, 1993, Volume: 38, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Cesarean Section; Death, Sudden, Cardiac; Electric

1993
Successful treatment of life-threatening ventricular tachycardia with high-dose propranolol under extracorporeal life support and intraaortic balloon pumping.
    Japanese circulation journal, 1993, Volume: 57, Issue:11

    Topics: Combined Modality Therapy; Extracorporeal Circulation; Heart Failure; Humans; Intra-Aortic Balloon P

1993
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.
    Journal of the American College of Cardiology, 1994, Volume: 23, Issue:2

    Topics: Animals; Captopril; Cardiac Pacing, Artificial; Hypertrophy, Left Ventricular; Male; Myocardial Infa

1994
Induction and the possible mechanism of ventricular tachycardia after catheter ablation with direct current shocks in dogs.
    European heart journal, 1993, Volume: 14, Issue:8

    Topics: Animals; Bundle of His; Cardiac Pacing, Artificial; Catheter Ablation; Dogs; Electrocardiography, Am

1993
Atrial natriuretic factor release during rapid ventricular pacing: interplay between autonomic and hemodynamic stimulants.
    American heart journal, 1993, Volume: 125, Issue:6

    Topics: Adult; Atrial Natriuretic Factor; Atropine; Autonomic Nervous System; Blood Pressure; Cardiac Pacing

1993
Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Methods and findings in experimental and clinical pharmacology, 1995, Volume: 17, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Disease Models, Animal; Dogs; Female; Ligation; M

1995
[Late potentials in high resolution ECG in thyroid gland dysfunction].
    Acta medica Austriaca, 1995, Volume: 22, Issue:4

    Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Humans; Hyperthyroidism;

1995
Phenylephrine-induced ventricular arrhythmias in dogs with inherited sudden death.
    Journal of cardiovascular electrophysiology, 1996, Volume: 7, Issue:3

    Topics: Animals; Atropine; Cardiac Pacing, Artificial; Death, Sudden; Dogs; Female; Genetic Predisposition t

1996
Exercise-induced ventricular tachycardia without demonstrable heart disease in childhood.
    Acta paediatrica Japonica : Overseas edition, 1996, Volume: 38, Issue:5

    Topics: Adolescent; Age Factors; Anti-Arrhythmia Agents; Child; Electrocardiography, Ambulatory; Exercise; E

1996
Role of sympathovagal balance in the initiation of idiopathic ventricular tachycardia originating from right ventricular outflow tract.
    Pacing and clinical electrophysiology : PACE, 1997, Volume: 20, Issue:10 Pt 1

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bundle-Branch Block; Female; Heart Rate; Human

1997
Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia.
    Journal of cardiovascular pharmacology, 1997, Volume: 30, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists;

1997
Circadian variation of idiopathic ventricular tachycardia originating from right ventricular outflow tract.
    The American journal of cardiology, 1999, Jul-01, Volume: 84, Issue:1

    Topics: Adult; Anti-Arrhythmia Agents; Circadian Rhythm; Electrocardiography, Ambulatory; Female; Heart Rate

1999
Disproportional response between refractory period and blood flow to alpha 1- and beta-adrenoceptor blockade in canine ischemic myocardium.
    Cardiovascular drugs and therapy, 1998, Volume: 12, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists;

1998
Successful treatment of chloral hydrate cardiac toxicity with propranolol.
    The American journal of emergency medicine, 1999, Volume: 17, Issue:5

    Topics: Adult; Anti-Arrhythmia Agents; Chloral Hydrate; Humans; Hypnotics and Sedatives; Male; Propranolol;

1999
Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.
    Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7

    Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; An

1999
Interaction between autonomic tone and the negative chronotropic effect of adenosine in humans.
    Pacing and clinical electrophysiology : PACE, 1999, Volume: 22, Issue:12

    Topics: Adenosine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine;

1999
Idiopathic sustained left ventricular tachycardia in pediatric patients.
    Pediatrics international : official journal of the Japan Pediatric Society, 2001, Volume: 43, Issue:1

    Topics: Adolescent; Anti-Arrhythmia Agents; Child; Child, Preschool; Electrophysiology; Female; Flecainide;

2001